Articles tagged with Vaccination
A nanosponge vaccine has been developed to combat MRSA toxins, triggering neutralizing antibodies and fighting off lethal doses in mice. The vaccine was found to be safer and more effective than traditional toxoid vaccines made from heat-treated staph toxin.
The University of Pittsburgh's Project Tycho has digitized all weekly surveillance reports for reportable diseases in the US since 1888, revealing patterns and insights into vaccine effectiveness. The database contains data on eight vaccine-preventable diseases, showing a resurgence of some diseases despite vaccination efforts.
A review of medical literature reveals financial concerns, parental attitudes, and social influences as key barriers to HPV vaccination among adolescents. The study emphasizes the importance of targeted guidance for healthcare professionals to improve vaccine uptake.
A Phase I clinical trial found that eight out of 16 patients with glioblastoma multiforme survived longer than five years, with median overall survival at 38.4 months. The treatment used an ICT-107 vaccine to alert the immune system to cancer cells and activate a tumor-killing response.
A new study suggests that rotavirus vaccination can also protect children against seizures, with a reduced risk of 20% compared to unvaccinated children. The researchers found that fully vaccinated children had fewer seizure-related hospitalizations and emergency department visits.
The University of Illinois has won Grand Challenges Explorations grants to develop a single-dose vaccine for multiple animal diseases and a system to study the microscopic parasite Cryptosporidium. This funding aims to address pressing disease problems in developing nations, improving animal health and productivity.
Researchers identified a genetic signature for respiratory syncytial virus (RSV), which causes severe pneumonia and bronchiolitis in infants. The discovery will help develop a vaccine and improve disease severity prediction using RNA profiles.
A study published in Neurosurgery found significant variations in hospitals' management of children with traumatic brain injury, particularly in ICP monitoring and craniectomy. The study analyzed data from over 7,000 children treated at 156 US hospitals and found that rates of these interventions varied significantly between hospitals.
Researchers at Northwestern University have successfully tested a nontoxic therapy that suppresses Lupus in blood samples of people with the autoimmune disease. The study found that the peptides can block and reduce autoantibody production to almost baseline levels, showing potential as a vaccine-like therapy.
A recent study published in Cancer Prevention Research found that women vaccinated with one dose of the human papillomavirus (HPV) vaccine had stable antibodies against HPV viruses in their blood for up to four years. The results challenge previous dogma on protein subunit vaccines requiring multiple doses for long-lived responses.
The study found that HPV vaccine initiation and completion rates were consistently lowest in the South, with 14% and 6% of women completing the series, respectively. The researchers believe regional disparities may be due to factors such as income, education, and insurance coverage.
A new DNA vaccine, p(Aβ3–10)10-C3d-p28, was developed to induce a Th2 immune response against amyloid-beta in Alzheimer's disease mice. The vaccine successfully elicited high titers of anti-amyloid-β antibodies and shifted the cellular immune response towards a Th2 phenotype.
A new study published in Pediatrics found that widespread vaccination of adolescents for pertussis was linked to a modest reduction in infant hospitalizations. The research suggests increasing vaccination rates among teens and adults is crucial to stem the ongoing pertussis epidemic among infants.
Many parents believe the HPV vaccine is unnecessary or unsafe, which poses a barrier to its success. Experts argue that clinicians must engage with parents and address their concerns through open conversations and science-based information. Social media may also play a role in future HPV vaccination programs.
A mass vaccination campaign of over 300,000 people in Guinea demonstrated the feasibility of using an oral cholera vaccine during a cholera outbreak. The campaign achieved high coverage rates and was well accepted by the local community.
A special issue of Preventive Medicine explores common misconceptions about the HPV vaccine, including concerns about sexual disinhibition and vaccine safety. Studies show that these fears are largely unfounded, and that the vaccine can help prevent cervical cancer and other HPV-associated cancers.
A clinical study published in The Lancet Infectious Diseases shows that an oral cholera vaccine (ShancholTM) provides sustained protection against cholera in humans for up to five years. This breakthrough finding has significant implications for vaccination strategies and cost-effectiveness in developing countries.
A new study explores why low-income parents, particularly those from minority groups, may not be getting the human papillomavirus (HPV) vaccine. English-speaking parents expressed concerns about the vaccine's need and safety, while Spanish-speaking parents feared the vaccine would encourage sexual activity due to lack of provider expla...
A Kaiser Permanente study found that children whose parents used an integrated personal health record were twice as likely to attend all recommended well-child care visits. The study also found a positive correlation between PHR use and immunization receipt, although the results in Hawaii were statistically non-significant.
A recent study found no significant increase in serious diseases among HPV-vaccinated girls compared to unvaccinated peers, despite monitoring over 900,000 participants. The researchers also noted that mild adverse reactions such as fever and swelling are common but not considered a concern.
A universal infant vaccination campaign in China has led to a doubling of Hepatitis B virus (HBV) mutations, which may enable the virus to evade the vaccine. The mutations have risen from 6.5% in 1992 to nearly 15% in 2005, necessitating new vaccination strategies.
A study found that Haitians rely heavily on traditional healers and religious leaders for health information, but struggle with Western medicine and vaccination uptake. The research highlights the need for more coordinated efforts to provide healthcare to the Haitian population.
A study by Tel Aviv University researchers reveals that nearly all pediatricians in Israel strongly support the vaccination of infants, with 92% agreeing it is in their best interest. However, 37% also agree that parents have a right to decide on medical care for their children.
The National Institutes of Health has awarded a nearly $1 billion contract to Saint Louis University's Center for Vaccine Development, recognizing the institution's leadership role in vaccine research. The seven-year contract will support clinical trials and lab studies for new vaccines, with a focus on emerging threats.
The updated guidelines offer recommendations for vaccination of household pet cats, shelter house cats, and cats in breeding catteries based on risk assessment. The new protocols prioritize comprehensive physical examinations and consultation to determine each cat's specific vaccination requirements.
A clinical trial found that a booster dose of the new meningitis B vaccine at 40 months of age can overcome waning immunity induced by infant vaccination, showing high antibody levels in 89%–100% of children against most strains.
Researchers at A*STAR have discovered a new personalized treatment strategy that utilizes a patient's own blood to treat chronic infections. By harnessing the power of monocytes, white blood cells can capture and utilize viruses to boost the immune response.
Scientists found that vaccinating cattle against E. coli O157 could reduce human cases of infection by nearly 85%, a significant improvement over previous estimates. The researchers used veterinary, human, and molecular data to estimate the impact of vaccinating cattle and predict that it would have a major public health benefit.
Researchers at Indiana University have developed a novel vaccine that effectively reduces the shedding of genital herpes virus, potentially providing a new treatment option for those affected. The vaccine, GEN-003, is one of the first to target viral shedding, which is often how the disease is spread.
A study by Jason M. Glanz and colleagues found that undervaccination with the DTaP vaccine increases the risk of pertussis in children aged 3-36 months. The research involved 72 cases of pertussis and 288 controls, showing that undervaccinated children were 18.56 times more likely to contract the disease than their vaccinated peers.
A study found that one-third of Walgreens vaccinations are administered during off-clinic hours, particularly among younger, healthy adults. This shift in vaccination access could measurably increase immunization rates in the US. Additionally, a new study suggests that eligible Medicaid beneficiaries under the Patient Protection and Af...
The nationwide HBV immunization program, launched in 1984, successfully lowered chronic HBV carrier prevalence, HCC incidence, and mortality of infant fulminant hepatitis in vaccinated birth cohorts. Long-term high-coverage immunization was associated with increased herd immunity and lower IFH mortality rates.
The study found that different PCV immunization schedules resulted in similar antibody levels in infants, with some schedules being superior for specific serotypes. The researchers conclude that optimal timing of the primary series is crucial to maintain optimal antibody levels during the period between the primary series and the boost...
The implementation of infant rotavirus vaccination has substantially reduced gastroenteritis hospitalizations among U.S. children and adults. Significant reductions were observed across all age groups, with the greatest declines seen in the late winter and early spring of 2008-2010.
Researchers found African-American women are 18.2% less likely to get vaccinated compared to white counterparts, despite access to healthcare. The study suggests health providers should bolster recommendations and address negative attitudes toward the vaccine.
A new study estimates the average cost per case of drug-resistant TB in the EU, revealing significant economic burden and support for investing in more effective vaccines. The study found that the costs of treating MDR-TB and XDR-TB cases exceed €170,000 and €170,000 respectively.
A randomized phase II trial is investigating a personalized vaccine made from a patient's own brain tumor, combined with Avastin, for treating recurrent glioblastoma multiforme. The trial aims to extend survival and slow tumor progression, offering new hope for patients with limited treatment options.
A new study by the American Society of Animal Science found that adult horses with low selenium levels have suppressed cell-mediated immunity, while antibody production remained unaffected. The researchers aimed to understand how different levels of selenium affect the immune system in horses.
A new vaccine has shown promise in boosting the immune system's ability to attack leukemia cells in post-transplant patients. The personalized tumor vaccine, which includes the patient's own irradiated leukemia cells combined with an immune stimulant, has been shown to induce a strong and selective immune response.
A clinical trial found that tumor cell vaccination increased complete remission rates and induced leukemia-specific T-cells in patients with advanced Chronic Lymphocytic Leukemia (CLL). The study suggests that this approach may enhance anti-tumor responses following allo-HSCT.
A new modular vaccine design called MAPS technology may generate vaccines conferring strong immunity at reduced cost and risk. The method allows for rapid construction of new vaccines that activate multiple arms of the immune system simultaneously against one or more pathogens, reducing the risk of adverse effects.
IDRI's VL vaccine candidate has shown safety and immunogenicity in healthy volunteers, and Zydus' expertise will be crucial in getting the vaccine to those who need it most. The partnership aims to make the vaccine affordable and accessible to all people in need, particularly in endemic countries.
Research by UNSW academics links human papillomavirus (HPV) to an increased risk of esophageal squamous cell carcinoma, a type of oesophageal cancer. HPV is one of several factors contributing to the development of OSCC, which is more prevalent in certain countries like China, South Africa, and Iran.
A new study from University of Toronto Professor Peter A. Newman reveals that vaccinating boys aged 11-21 is crucial for reducing cancer rates across sexes. The lack of a well-established connection between HPV in men and life-threatening illnesses hinders male vaccination rates.
A study by Columbia Nursing researchers found that automated reporting of immunization data through EHRs increased knowledge about individuals and communities, allowing medical and public health officials to make informed decisions. This led to reduced lag times, improved documentation, and enhanced efficiency in vaccine tracking.
A clinical trial assessing an anti-melanoma vaccine found that it enhances the effectiveness of the immune system by increasing IL-12p70 production. Six out of seven patients exhibited a vaccine-stimulated immune response, with three showing clinically significant changes in tumor progression.
Researchers at the University of British Columbia have developed a vaccine to protect birds against West Nile Virus (WNV), which has killed over 300 people in North America. The vaccine, made from WNV components, generated an effective immune response in birds and may also offer protection against other species.
Less than one third of obstetrician-gynecologists vaccinate patients against HPV, while only half follow cervical cancer prevention guidelines. Physician-patient interactions are a major barrier to guideline implementation.
A study by NYU Langone researchers found that states with simpler vaccination exemption processes have higher non-medical exemption rates, contributing to outbreaks of childhood infections. States with looser requirements are more likely to see parents opt-out of vaccinating their children, putting others at risk.
A cancer doctor turned to immunotherapy after his Great Dane's lung cancer diagnosis. The treatment, using an engineered vaccine, significantly prolonged the dog's life and has sparked interest in testing on human brain cancer patients.
Researchers have developed a novel vaccination method using gold nanoparticles that can deliver specific proteins to the body's immune cells. The technique mimics viruses and stimulates an immune response, offering significant safety advantages.
Researchers at University of Helsinki and ETH Zurich have solved the three-dimensional structure of RSV, a common cause of respiratory infection. The structural model provides valuable information for intelligent vaccine design, targeting the virus's fusion protein and matrix protein.
Researchers have developed a vaccine that provides at least 60 percent protection against rotavirus in newborns, significantly reducing severe dehydration and hospitalizations. The study, published in the Journal of Infectious Diseases, suggests that early administration of the vaccine could save thousands of lives annually.
A new study on an anti-nicotine vaccination found mixed results, with some patients experiencing a decrease in brain nicotine accumulation but others showing an increase. The study used PET imaging to test the vaccine's effectiveness, revealing that high-affinity antibodies were associated with decreased brain nicotine accumulation.
Researchers have created a powerful digital system, SALSA, to analyze billions of tweets and social media messages in just seconds. The tool helps emergency responders receive early information about natural disasters and public health advocates protect people's health by identifying valuable patterns amidst vast amounts of noise.
Researchers at the University of Exeter have developed a vaccine that protects against necrotic enteritis, a severe poultry disease caused by Clostridium perfringens. The vaccine targets the bacterium's NetB toxin, allowing for effective prevention and control of the devastating disease.
The first-ever enterovirus 71 vaccine has been shown to be highly effective in protecting young children against the potentially deadly hand, foot, and mouth disease. The vaccine demonstrated 90% protection against clinical EV71-associated HFMD and 80.4% against EV71-associated disease for at least 12 months.
A new 13-valent pneumococcal conjugate vaccine (PCV13) has been found to be as safe as the previously used 7-valent PCV7, according to a Kaiser Permanente study. The vaccine protects against a broader range of pneumococcal types and provides protection against serious infections such as meningitis.
A new oral vaccine against ETEC has been developed and shown to be safe and highly immunogenic in a phase I study, inducing immune responses in all volunteers. The vaccine is designed to protect travelers and children living in areas endemic for ETEC.
A University of Michigan-led study challenges prevailing theories on whooping cough's resurgence by showing vaccines offer long-lived protection and reduced transmission. The study highlights the success of Thailand's childhood immunization program in reducing pertussis cases, especially among infants.